XML 41 R32.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Fair Value of Financial Instruments and Fair Value Measurements (Details) - USD ($) | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2022 | Dec. 31, 2021 | Dec. 31, 2020
Fair Value of Financial Instruments and Fair Value Measurements (Details) [Line Items] |  |  |
Net realized gain |  | $ 6,660,483 |
Equity investments cost |  | 0 | $ 200
Common stock grant date fair value | $ 85,733 |  |
Common stock grant date fair value per share (in Dollars per share) | $ 1.1 |  |
DatChat, Inc. [Member] |  |  |
Fair Value of Financial Instruments and Fair Value Measurements (Details) [Line Items] |  |  |
Net realized gain |  | 6,657,120 |
Basic investment cost |  | 200 |
Commission on sales |  | 578,880 |
Aikido Pharma, Inc. [Member] |  |  |
Fair Value of Financial Instruments and Fair Value Measurements (Details) [Line Items] |  |  |
Net realized gain |  | $ 3,363 |
Equity investment Sold | $ 171,407 |  |
Gross proceeds | 66,707 |  |
Equity investments amount | $ 104,700 |  |
Home Bistro, Inc. [Member] |  |  |
Fair Value of Financial Instruments and Fair Value Measurements (Details) [Line Items] |  |  |
Company received shares (in Shares) | 77,939 |  |

X
- Definition Common stock grant date fair value per share. + References No definition available. + Details
Name: | silo_CommonStockGrantDateFairValuePerShare
Namespace Prefix: | silo_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Company received shares. + References No definition available. + Details
Name: | silo_CompanyReceivedShares
Namespace Prefix: | silo_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity investments cost. + References No definition available. + Details
Name: | silo_EquityInvestmentsCost
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. + References No definition available. + Details
Name: | silo_EquityMethodInvestment
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | silo_FairValueofFinancialInstrumentsandFairValueMeasurementsDetailsLineItems
Namespace Prefix: | silo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The value of Gross proceeds. + References No definition available. + Details
Name: | silo_GrossProceeds
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Carrying amount of advanced commission payments. + References No definition available. + Details
Name: | us-gaap_DeferredSalesCommission
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258 + Details
Name: | us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings and not to the cash proceeds of the sale. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(3)(a)) -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(13)) -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(b)(9)(a)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(b)(7)(c)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 + Details
Name: | us-gaap_GainOnSaleOfInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Fair value as of the balance sheet date of all derivatives not designated as hedging instruments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 45 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126966630&loc=d3e41228-113958 + Details
Name: | us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Cost of the investment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 210 -Section 50 -Paragraph 6 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841 + Details
Name: | us-gaap_InvestmentOwnedAtCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=silo_DatChatIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=silo_AikidoPharmaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=silo_HomeBistroIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |